This hypothesis is supported by data on Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an animal model of type 2 diabetes with obesity, hence long-term administration of recombinant PEDF significantly improved body weight, metabolic parameters and insulin resistance [59]. This evidence concerns the gene SERPINF1 and obesity disorder.